Blueprint Medicines Corporation BPMC reported third-quarter 2024 adjusted loss of 89 cents per share, narrower than the Zacks Consensus Estimate of a loss of 97 cents. The company had incurred a ...
Hosted on MSN17d
Blueprint Medicines Q3 2024 Earnings PreviewBlueprint Medicines Corporation 2024 Q2 - Results - Earnings Call Presentation Blueprint Medicines GAAP EPS of -$0.80 beats by $0.49, revenue of $138.16M beats by $34.22M Seeking Alpha’s Quant ...
Third Quarter 2024 Results Key Financial Results Revenue: US$128.2m (up 127% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback